Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis
Condition: Transcatheter Aortic Valve Implantation Intervention: Device: (ALLEGRA Plus Transcatheter Heart Valve) TAVI in severe calcified aortic stenosis or in failed surgical aortic bioprosthesis Sponsor: NVT GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allegra | Aortic Stenosis | Cardiology | Heart | Heart Valve Disease | Heart Valves | Research